AVX Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 121428 1 Year -0.01 -25.00
52 Week High 0.04
52 Week Low 0.02
AVX Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.03
Support 1 0.03
Support 2 0.03
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GPP 0.04 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMI 0.02 100.00%
RMI 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
AZM 0.04 33.33%
AZM 0.04 33.33%
AZM 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
ADX 0.01 -50.00%
ADX 0.01 -50.00%
ADX 0.01 -50.00%
NDO 0.04 -33.33%
More..

Avexa Ltd (ASX: AVX)

AVX Technical Analysis 1.5
As on 9th Dec 2016 AVX Share Price closed @ 0.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.03 & Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
AVX Target for February
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
AVX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.avexa.com.au
AVX Address
AVX
61-63 Camberwell Road
Level 1
Hawthorn East, VIC 3123
Australia
Phone: 61 3 9208 4300
Fax: 61 3 9208 4146
AVX Latest News
FEE rebrands as Accountancy Europe   Public Finance International   - 08th Dec 16
William Demant Group opened a new Software R&D office in Poland   Warsaw Business Journal   - 20th Sep 16
Dakota soy makes strides as fishmeal substitute   Prairie Business   - 22nd Aug 16
Noble Metals Ltd bags funding for Colombian gold operations   Proactive Investors Australia   - 25th Jul 16
People's Artist of Ukraine throws down a gag to PKP on YouTube   Warsaw Business Journal   - 27th Apr 16
Made in Poland 2016   Warsaw Business Journal   - 07th Apr 16
Three Poles appear in Panama Papers leak   Warsaw Business Journal   - 04th Apr 16
Researchers identify molecule needed for sperm activation   National Institutes of Health (press release)   - 17th Mar 16
Novita Technologies expanding in Hendersonville   Nashville Business Journal (blog)   - 16th May 14
Novita Therapeutics spins off two new companies, closes doors   Kansas City Business Journal   - 21st Feb 14
Interactive Technical Analysis Chart Avexa Ltd ( AVX ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Avexa Ltd
AVX Business Profile
Avexa Limited, a biotechnology company, discovers and develops anti-infective pharmaceutical medicines for the treatment of human infectious diseases. The company’s research programs primarily focus on the discovery of medicines for the treatment of the diseases caused by human immunodeficiency virus (HIV) and vancomycin-and methicillin-resistant bacteria. Its primary project includes apricitabine (ATC) for the treatment of drug resistant HIV, an HIV integrase program and an antibiotic program for antibiotic-resistant bacterial infections. The company was founded in 2004 and is based in Hawthorn East, Australia.